NO2776955T3 - - Google Patents

Info

Publication number
NO2776955T3
NO2776955T3 NO12848689A NO12848689A NO2776955T3 NO 2776955 T3 NO2776955 T3 NO 2776955T3 NO 12848689 A NO12848689 A NO 12848689A NO 12848689 A NO12848689 A NO 12848689A NO 2776955 T3 NO2776955 T3 NO 2776955T3
Authority
NO
Norway
Application number
NO12848689A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2776955T3 publication Critical patent/NO2776955T3/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO12848689A 2011-08-30 2012-11-09 NO2776955T3 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161528893P 2011-08-30 2011-08-30

Publications (1)

Publication Number Publication Date
NO2776955T3 true NO2776955T3 (no) 2018-06-02

Family

ID=46829875

Family Applications (1)

Application Number Title Priority Date Filing Date
NO12848689A NO2776955T3 (no) 2011-08-30 2012-11-09

Country Status (22)

Country Link
US (1) US9512140B2 (no)
EP (1) EP2751115B1 (no)
JP (1) JP6042436B2 (no)
KR (1) KR101596607B1 (no)
CN (1) CN103958523B (no)
AU (1) AU2012300451B2 (no)
BR (1) BR112014004557A2 (no)
CA (1) CA2843514C (no)
DK (1) DK2751115T3 (no)
EA (1) EA024248B1 (no)
ES (1) ES2650225T3 (no)
HR (1) HRP20171824T1 (no)
HU (1) HUE034845T2 (no)
LT (1) LT2751115T (no)
MX (1) MX350419B (no)
NO (1) NO2776955T3 (no)
PL (1) PL2751115T3 (no)
PT (1) PT2751115T (no)
RS (1) RS56537B1 (no)
SI (1) SI2751115T1 (no)
WO (1) WO2013032804A1 (no)
ZA (1) ZA201400874B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112014000379A2 (pt) * 2011-07-08 2017-01-10 Lilly Co Eli compostos de (trieno[2,3-1)][1,5]benzoxazepin-4-il)piperazin-1-ila como atividade dupla de antagonistas de 5-ht2a /agonistas inversos de h1
DK2943498T3 (en) 2013-01-14 2017-10-23 Lilly Co Eli (THIENO [2,3-B] [1,5] BENZOXAZEPIN-4-YL) PIPERAZIN-1-YL COMPOUNDS AS H1-INVERSE AGONISTS / 5-HT2A DOUBLE EFFECTS
TW201625644A (zh) 2014-04-29 2016-07-16 美國禮來大藥廠 作為選擇性5-HTA反向促效劑之(噻吩并[2,3-b][1,5]苯并氧氮呯-4-基)哌嗪-1-基化合物
WO2018177993A1 (de) 2017-03-31 2018-10-04 Bayer Cropscience Aktiengesellschaft Pyrazole zur bekämpfung von arthropoden
WO2018234488A1 (en) 2017-06-23 2018-12-27 Basf Se SUBSTITUTED CYCLOPROPYL DERIVATIVES
WO2019185413A1 (en) 2018-03-27 2019-10-03 Basf Se Pesticidal substituted cyclopropyl derivatives
CN113767094A (zh) * 2018-12-21 2021-12-07 奥格达股份有限公司 3-甲基-1,2,4-噻二唑-5-碳酰肼及其甲基-d3氘代形式的合成
MX2023009402A (es) 2021-02-11 2023-08-23 Basf Se Derivados de isoxazolina sustituida.
EP4043444A1 (en) 2021-02-11 2022-08-17 Basf Se Substituted isoxazoline derivatives
WO2024089216A1 (en) 2022-10-27 2024-05-02 Syngenta Crop Protection Ag Novel sulfur-containing heteroaryl carboxamide compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7395251B2 (en) * 2005-07-01 2008-07-01 International Business Machines Corporation Neural networks for prediction and control
US7807828B2 (en) * 2005-08-11 2010-10-05 Hypnion, Inc. Olanzapine analogs and methods of use thereof

Also Published As

Publication number Publication date
JP2014525440A (ja) 2014-09-29
PT2751115T (pt) 2017-12-20
AU2012300451B2 (en) 2016-10-13
CN103958523A (zh) 2014-07-30
KR20140051355A (ko) 2014-04-30
ZA201400874B (en) 2015-10-28
CA2843514C (en) 2017-01-10
KR101596607B1 (ko) 2016-02-22
HRP20171824T1 (hr) 2017-12-29
EA024248B1 (ru) 2016-08-31
US9512140B2 (en) 2016-12-06
PL2751115T3 (pl) 2018-02-28
RS56537B1 (sr) 2018-02-28
MX350419B (es) 2017-09-05
EA201490332A1 (ru) 2014-06-30
WO2013032804A1 (en) 2013-03-07
HUE034845T2 (en) 2018-03-28
BR112014004557A2 (pt) 2017-05-30
DK2751115T3 (en) 2017-10-23
EP2751115A1 (en) 2014-07-09
ES2650225T3 (es) 2018-01-17
US20140171411A1 (en) 2014-06-19
CN103958523B (zh) 2016-07-27
JP6042436B2 (ja) 2016-12-14
SI2751115T1 (sl) 2017-11-30
EP2751115B1 (en) 2017-09-20
LT2751115T (lt) 2017-12-27
AU2012300451A1 (en) 2014-01-30
MX2014002473A (es) 2016-09-26
CA2843514A1 (en) 2013-03-07

Similar Documents

Publication Publication Date Title
BR112013022641A2 (no)
AP3853A (no)
BR112013031251A2 (no)
BR112013027245A2 (no)
BR112013024383A2 (no)
BR112013026905A2 (no)
BR112013023185A2 (no)
BR112013022995A2 (no)
BR112013026744A2 (no)
BR112013017670A2 (no)
BR112013023927A2 (no)
BR112013027830A2 (no)
BR112013024365A2 (no)
BR112013028733A2 (no)
BR112013027121A2 (no)
BR112013027452A2 (no)
BR112013031556A2 (no)
BR112013026790A2 (no)
BR112013024588A2 (no)
BR112013032377A2 (no)
BR112013032380A2 (no)
BR112013032366A2 (no)
BR112013018949A2 (no)
BR112013026895A2 (no)
BR112013027761A2 (no)